CS logo
small CS logo
Hospital Universitario La Fe Servicio de Neurología

Valencia, Spain
Hospital in Valencia
Avinguda de Fernando Abril Martorell, 106, 46026 València, Valencia

About Hospital Universitario La Fe Servicio de Neurología


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
12
Genentech, Inc.
1
Institut de Recherches Internationales Servier
1
Total Rows: 3

Clinical Trials at Hospital Universitario La Fe Servicio de Neurología


During the past decade, Hospital Universitario La Fe Servicio de Neurología conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years330044113333000000001111Started TrialsCompleted Trails2016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
2016-09-09
2020-12-15
Completed
681
Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event
2016-12-19
2019-03-10
Completed
585
Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-08-22
2022-11-28
Terminated
982
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
2018-05-28
2026-12-04
Active, not recruiting
927
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
2018-11-12
2025-07-26
Active, not recruiting
1,700
This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)
2018-07-12
2025-08-26
Recruiting
1,500
A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants With Manifest Huntington's Disease
2019-01-23
2022-03-17
Completed
899

Rows per page:

1–14 of 14

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario La Fe Servicio de Neurología" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "Prothena Biosciences Limited" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 12Hoffmann-La Roche: 12Genentech, Inc.: 1Genentech, Inc.: 1Institut de RecherchesInternationales Servier:1Institut de RecherchesInternationales Servier:1

Created with Highcharts 11.1.0Top CollaboratorsADIR, a Servier Groupcompany: 1ADIR, a Servier Groupcompany: 1Chugai Pharmaceutical: 1Chugai Pharmaceutical: 1Prothena Biosciences Limited: 1Prothena Biosciences Limited: 1

Clinical Trials Conditions at Hospital Universitario La Fe Servicio de Neurología


According to Clinical.Site data, the most researched conditions in "Hospital Universitario La Fe Servicio de Neurología" are "Alzheimer Disease" (4 trials), "Multiple Sclerosis" (2 trials), "Alzheimer's Disease" (1 trials), "Generalized Myasthenia Gravis" (1 trials) and "Huntingtons Disease" (1 trials). Many other conditions were trialed in "Hospital Universitario La Fe Servicio de Neurología" in a lesser frequency.

Clinical Trials Intervention Types at Hospital Universitario La Fe Servicio de Neurología


Most popular intervention types in "Hospital Universitario La Fe Servicio de Neurología" are "Drug" (13 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Gantenerumab" (4 trials), "Ocrelizumab" (4 trials), "BFKB8488A" (1 trials) and "Crenezumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital Universitario La Fe Servicio de Neurología


The vast majority of trials in "Hospital Universitario La Fe Servicio de Neurología" are 14 trials for "All" genders.

Clinical Trials Status at Hospital Universitario La Fe Servicio de Neurología


Currently, there are NaN active trials in "Hospital Universitario La Fe Servicio de Neurología". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Universitario La Fe Servicio de Neurología, undefined suspended trials, and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario La Fe Servicio de Neurología, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 9Phase 3: 9Phase 2: 4Phase 2: 4

Created with Highcharts 11.1.0Trials StatusTerminated: 5Terminated: 5Completed: 4Completed: 4Active, not recruiting: 3Active, not recruiting: 3Recruiting: 2Recruiting: 2